OncoSec Medical, Inc. (ONCSQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
OncoSec Medical Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2023 | -5.486M |
| October 31, 2022 | -0.9844M |
| July 31, 2022 | 6.118M |
| April 30, 2022 | 13.89M |
| January 31, 2022 | 19.82M |
| October 31, 2021 | 28.78M |
| July 31, 2021 | 38.08M |
| April 30, 2021 | 47.41M |
| January 31, 2021 | 48.14M |
| October 31, 2020 | 16.23M |
| July 31, 2020 | 13.87M |
| April 30, 2020 | 21.70M |
| January 31, 2020 | 3.175M |
| October 31, 2019 | 15.30M |
| July 31, 2019 | 24.28M |
| April 30, 2019 | 21.18M |
| January 31, 2019 | 24.67M |
| October 31, 2018 | 25.20M |
| July 31, 2018 | 22.92M |
| April 30, 2018 | 32.70M |
| January 31, 2018 | 18.03M |
| October 31, 2017 | 13.54M |
| July 31, 2017 | 10.70M |
| April 30, 2017 | 15.96M |
| January 31, 2017 | 19.70M |
| Date | Value |
|---|---|
| October 31, 2016 | 23.64M |
| July 31, 2016 | 28.05M |
| April 30, 2016 | 23.99M |
| January 31, 2016 | 28.59M |
| October 31, 2015 | 27.22M |
| July 31, 2015 | 32.70M |
| April 30, 2015 | 25.89M |
| January 31, 2015 | 31.21M |
| October 31, 2014 | 34.62M |
| July 31, 2014 | 38.07M |
| April 30, 2014 | 24.52M |
| January 31, 2014 | 18.89M |
| October 31, 2013 | 15.20M |
| July 31, 2013 | 4.739M |
| April 30, 2013 | 6.378M |
| January 31, 2013 | 8.016M |
| October 31, 2012 | 2.685M |
| July 31, 2012 | 4.426M |
| April 30, 2012 | 5.808M |
| January 31, 2012 | -2.040M |
| October 31, 2011 | 0.5808M |
| July 31, 2011 | -2.365M |
| April 30, 2011 | 0.5557M |
| January 31, 2011 | -0.0369M |
| October 31, 2010 | -0.0325M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |